ADVERTISEMENT

Dr Lal PathLabs, Emami, Havells Among Citi's Top Midcap Bets

Dr Lal PathLabs made a stellar debut in stock markets last year
Dr Lal PathLabs made a stellar debut in stock markets last year

The Bombay Stock Exchange's sub-index of midcap stocks is up 10 per cent over the last one year as compared to 1 per cent dip in the broader Sensex.

This outperformance in midcap stocks vis-a-vis large cap stocks has led to convergence in valuations, says global investment bank Citi.

Large cap stocks, however, are better on growth and return ratios, it added.

Citi's top midcap picks are Apollo Hospital, Container Corp, Dish TV, Dr Lal PathLabs, Emami, Exide, Federal Bank, GSPL, Havells India and Petronet.